20Feb 2019

STUDY OF SERUM ADIPONECTIN, LEPTIN AND CHEMERIN LEVELS INPATIENTS WITH TYPE 2 DIABETES MELLITUS AND OBESITY.

  • KPC Medical College & Hospital, Kolkata.
  • Institute of Post-Graduate Medical Education and Research, A.J.C. Bose Road, Kolkata-700020, West Bengal, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

This cross sectional study was done in the Department of Biochemistry, K.P.C. Medical College, Jadvapur, Kolkata. A total of 200 male patients of more than 18 years were studied. 200 patients were divided into Case and Control group depending on presence of diabetes mellitus. Each group consist of 100 patients. In the present research, we showed that adiponectin was significantly higher in non diabetic control group with p< 0.001. In diabetic patients, adiponectin was suppose to be lower than normal. Statistically significant alliance was demonstrated in between Chemerin and Diabetes (p<0.001). Chemerin values were raised in diabetic individuals. Here, chemerin had statistically significant positive correlation with Cholesterol and triglycerides where p<0.001 & p=0.003 respectively. Similiarly, Lipoproteins like HDL, LDL and VLDL too had positive correlation with chemerin but of no statistical significance where p = 0.585, p= 0.253, p= 0.147 respectively. Glycemic parameters like FBS, PPBS and HbA1c were found to be positively correlated to chemerin with pronounced statistical significance (p<0.001 for each). Similar to Leptin, it was observed that chemerin too had positive correlation of statistical significance with HOMA -IR (p<0.001). This study concluded that there is a strong association of each of the parameters, namely serum adiponectin, leptin and chemerin with diabetes as well as obesity.

  1. Joshi SR, Parikh RM India?diabetes capital of the world :now heading towards hypertension. J Assoc Physicians India. 2007;55:323-4.
  2. Kumar A, Goel MK, Jain RB, Khanna P, Chaudhary V. India towards diabetes control: Key issues. Australas Med J. 2013;6(10):524-31.
  3. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996;2:800-2.
  4. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture Cell.1996;87:377-89.
  5. Burtis A, Ashwood R, Bruns E, editors.Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. New Delhi: Elsevier Inc.; 2006: 1024.
  6. Wannamethee SG. Tchernova J. Whincup P. Lowe GDO. Kelley A. Rumley A. Wallace AM. Sattar N. Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2007;191:418?26
  7. Kieffer TJ. Heller RS. Leech CA. Holz GG. Habener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes.1997;46:1087?93
  8. Kulkarni RN. Wang ZL. Wang RM. Hurley JD. Smith DM. Ghatei MA. Withers DJ. Gardiner JV. Bailey CJ. Bloom SR. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest. 1997;100:2729?36.
  9. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J PhysiolEndocrinolMetab. 2002;283:E187?E192.
  10. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes. 1996;45:822?4.
  11. Sumner AE, Falkner B, Kushner H, Considine RV. Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans. Obes Res.1998;6:128?33.
  12. Maahs DM. Hamman RF. D'Agostino R., Jr Dolan LM. Imperatore G. Lawrence JM. Marcovina SM. Mayer-Davis EJ. Pihoker C. Dabelea D. The association between adiponectin/leptin ratio and diabetes type: the SEARCH for Diabetes in Youth Study. J Pediatr. 2009;155:133?5.
  13. Wannamethee SG. Lowe GD. Rumley A. Cherry L. Whincup PH. Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care. 2007;30:1200?5.
  14. Welsh P. Murray HM. Buckley BM. de Craen AJM. Ford I. Jukema JW. Macfarlane PW. Packard CJ. Stott DJ. Westendorp RGJ. Shepherd J. Sattar N. Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population.Diabetes Care. 2009;32:308?10.
  15. McNeely MJ. Boyko EJ. Weigle DS. Shofer JB. Chessler SD. Leonnetti DL. Fujimoto WY. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care. 1999;22:65?70.
  16. Soderberg S. Zimmet P. Tuomilehto J. Chitson P. Gareeboo H. Alberti KGMM. Shaw JE. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) 2007;31:1126?33.
  17. Schmidt MI. Duncan BB. Vigo A. Pnakow JS. Couper D. Ballantyne CM. Hoogeveen RC. Heiss G. for the ARIC Investigators. Leptin and incident type 2 diabetes: risk or protection? Diabetologia. 2006;49:2086?96.
  18. Sun Q, van Dam RM. Meigs JB. Franco OH. Mantzoros CS. Hu FB. Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: A prospective study. Diabetes. 2010 Mar; 59(3):611?8.
  19. Bozaoglu K, Bolto K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology,2007; 148, 4687?94.
  20. Roh SG, Song SH, Choi KC, et al. Chemerin ? a new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications, 2007; 362, 1013?8.
  21. Wittamer V , Bondue? B , Guillabert? A, et al. Neutrophilmediated maturation of chemerin: a link between innate and adaptive immunity. Journal of Immunology, 2005; 175, 487?93.
  22. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. The Journal of Experimental Medicine, 2003;198, 977?85.
  23. Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. The Journal of Biological Chemistry, 2005; 280, 34661?6.
  24. Parolini S, Santoro A, Marcenaro E, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007; 109, 3625?2.
  25. RohS,Song S, Choi K,et al. ?Chemerin?a new adipokine that modulates adipogenesis via its own receptor,? Biochemicaland Biophysical Research Communications.2007; 362(4 )1013?8.
  26. Goralski KB, McCarthy TC, Hanniman EA ,et al. ?Chemerin, a novel adipokine that regulates adipogenesis and adipocytemetabolism,? Journal of Biological Chemistry.2007; 282(38) 28175?88,
  27. Bozaoglu K, Segal D, Shields KA,et al .?Chemerin is associated with metabolic syndrome phenotypes in a Mexican- American population,?The Journal of Clinical Endocrinology &Metabolism. 2009; 94(8) 3085?8.
  28. Looker HC, Krakoff J, Funahashi T, Matsuzawa Y, Tanaka S, Nelson RG, et al. The Journal of Clinical Endocrinology & Metabolism. 2004;89:4010-17.
  29. Abdelgadir, M. Elbagir, M. Eltom, C. Berne, B. Ahr[eacute].Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan. 2002 Mar;51(3):304-6.
  30. Coimbra S, Proen?a JB, Santos-Silva A, Neuparth MJ. Adiponectin, Leptin, and Chemerin in Elderly Patients with Type 2 Diabetes Mellitus: A Close Linkage with Obesity and Length of the Disease. BioMed Research International. 2014;Article ID 701915:8 pages.
  31. Abdullah SG, Mohammed AA. Mechanism linking diabetes mellitus and obesity. Dovepress. 2014 Dec;7 :587-591.
  32. Staiger H, Tschritter O, Machann J, ThamerC.Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 2003 Mar;11(3):368-72.
  33. Phillips SA, Ciaraldi TP, Kong APS, Bandukwala R, Aroda V, Carter L, et al. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes. 2003;52:667?74.
  34. Smith J, Al-Amri M, SnidermanA ,KatherineCianflone. Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasianmen and women. Nutrition & Metabolism. 2006; 3:18.
  35. Association Between Plasma Leptin Levels and Diabetes Mellitus. METABOLIC SYNDROME AND RELATED DISORDERS. 2011;9(1).
  36. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology. 2010;72:342?8
  37. Li Y, Shi B, Li S. Association between Serum Chemerin Concentrations and Clinical Indices in Obesity or Metabolic Syndrome: A Meta-Analysis. 2014 DEC 14. DOI: 10.1371/journal.pone.0113915.

[Tirtha Raj Sen, Indira Bhaskar Biswas and Debarshi Jana. (2019); STUDY OF SERUM ADIPONECTIN, LEPTIN AND CHEMERIN LEVELS INPATIENTS WITH TYPE 2 DIABETES MELLITUS AND OBESITY. Int. J. of Adv. Res. 7 (Feb). 626-634] (ISSN 2320-5407). www.journalijar.com

Dr.Debarshi Jana
Institute of Post-Graduate Medical Education and Research, A.J.C. Bose Road, Kolkata-700020, West Bengal, India

DOI:

Article DOI: 10.21474/IJAR01/8530      
DOI URL: https://dx.doi.org/10.21474/IJAR01/8530

Download Full Paper

Download PDF No. of Downloads: 20 | No. of Views: 71